Zante Greg's Form 4 filing
Viking Therapeutics, Inc. (VKTX) · filed Apr 13, 2023
- Accession no.
- 0001209191-23-024227
- Filed
- Apr 13, 2023
- Trade date
- Apr 11-12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 6 derivative transactions. Open-market sales total $1.76M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zante GregCIK 0001264949 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +3,242 | $7.77 | +$25,190.34 | 152,521 | Direct | |
| Apr 11, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +8,500 | $4.68 | +$39,780 | 161,021 | Direct | |
| Apr 11, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +30,000 | $4.88 | +$146,400 | 191,021 | Direct | |
| Apr 11, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +14,553 | $5.80 | +$84,407.4 | 205,574 | Direct | |
| Apr 11, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −56,295 | $18.00 | −$1,013,310 | 149,279 | Direct | |
| Apr 12, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +37,447 | $5.80 | +$217,192.6 | 186,726 | Direct | |
| Apr 12, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +4,097 | $7.77 | +$31,833.69 | 190,823 | Direct | |
| Apr 12, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −41,544 | $18.00 | −$747,792 | 149,279 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2023 | Common Stock | MOption exerciseDisposed | −3,242 | $0.00 | $0 | 16,847 | Direct | |
| Apr 11, 2023 | Common Stock | MOption exerciseDisposed | −8,500 | $0.00 | $0 | 8,500 | Direct | |
| Apr 11, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 90,000 | Direct | |
| Apr 11, 2023 | Common Stock | MOption exerciseDisposed | −14,553 | $0.00 | $0 | 63,447 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −37,447 | $0.00 | $0 | 26,000 | Direct | |
| Apr 12, 2023 | Common Stock | MOption exerciseDisposed | −4,097 | $0.00 | $0 | 12,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.